Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
personalized treatments
MedTech
Invitae launches personalized blood tests to spot cancer relapse
The company’s Personalized Cancer Monitoring platform includes a set of assays that are tailored to a patient’s particular tumor.
Conor Hale
Mar 17, 2022 10:20am
Vineti nets $35M to expand logistics software for cell therapy
Feb 6, 2020 9:18am
Pact Pharma launches a trial of its CAR-T for solid tumors
Jul 22, 2019 9:20am
AZ's Baselga on tailored treatments and the march to cure cancer
Jun 4, 2019 11:10am
Personalizing Crohn’s therapies with microRNA as marker
Oct 4, 2018 9:00am
Gritstone Oncology files for $80M IPO
Aug 23, 2018 1:35pm
